2020
DOI: 10.1016/j.jtcme.2019.08.002
|View full text |Cite
|
Sign up to set email alerts
|

HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies

Abstract: Background and aim Lignosus rhinocerus (LR) is an edible mushroom with a variety of medicinal properties such as neurostimulation, immunomodulation, anti-inflammation, anti-oxidation, anti-proliferation, anti-diabetes and especially antiviral activity. Human immunodeficiency virus type-1 (HIV-1) needs the HIV-1 protease (PR) and reverse transcriptase (RT) for its replication. Therefore, both HIV-1 PR and RT are important targets for antiretroviral drug development. Ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 51 publications
(50 reference statements)
1
21
0
Order By: Relevance
“…Twenty-five metabolites were isolated from the fruiting body of G. sinnense, and it was found that ganoderic acid GS-2, 20-hydroxylucidenic acid N, 20(21)-dehydrolucidenic acid N and ganoderiol F exhibited a high potential to inhibit HIV-1 protease activity [83]. Notably, crude extracts of tiger milk mushroom (Lignosus rhinocerus) displayed inhibitory activity against HIV-1 protease activity on infected cells, while in silico analysis showed that heliantriol F displayed significant binding energy at -12.57 kcal/mol on the active site of HIV-1 protease [84]. Hexane extract fractions obtained from a jelly fungus (Auricularia polytricha) could effectively inhibit HIV-1 protease activity in vitro, while four major compounds, ergosterol, linoleic acid and two triacylglycerols were found to be present [85].…”
Section: Hiv-1 Protease Inhibitors Isolated From Fungimentioning
confidence: 99%
“…Twenty-five metabolites were isolated from the fruiting body of G. sinnense, and it was found that ganoderic acid GS-2, 20-hydroxylucidenic acid N, 20(21)-dehydrolucidenic acid N and ganoderiol F exhibited a high potential to inhibit HIV-1 protease activity [83]. Notably, crude extracts of tiger milk mushroom (Lignosus rhinocerus) displayed inhibitory activity against HIV-1 protease activity on infected cells, while in silico analysis showed that heliantriol F displayed significant binding energy at -12.57 kcal/mol on the active site of HIV-1 protease [84]. Hexane extract fractions obtained from a jelly fungus (Auricularia polytricha) could effectively inhibit HIV-1 protease activity in vitro, while four major compounds, ergosterol, linoleic acid and two triacylglycerols were found to be present [85].…”
Section: Hiv-1 Protease Inhibitors Isolated From Fungimentioning
confidence: 99%
“…The Tiger Milk Mushroom Lignosus rhinocerus (LR), found in Southeast Asia and China, has been used in folk medicine for asthma treatment [ 9 ]. Furthermore, this mushroom has anti-inflammatory, antioxidant, anti-proliferative, immuno-modulating and anti-HIV-1 activities in addition to a promotion of neurite outgrowth in PC-12 cells [ 10 , 11 , 12 ]. The bioactive compounds of LR consist of 1,3-β- and 1,6-β-glucans which are in a group of β-D-glucose polysaccharides, lectin which is a glycoprotein, laccase which is a copper-containing oxidase enzyme and other fungal immune-modulatory proteins (FIPs), and antioxidant proteins [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, these bioactive molecules with antiviral effect have been classified as polyketides, indole alkaloids, terpenoids, nonribosomal peptides, polyketides, and hybrids of non-ribosomal peptides, fatty acids, ergosterol peroxide etc. These fungal bioactive compounds have been reported to be produced by Lignosus, Penicillium, Stachybotrys, Aspergillus, Cladosporium, Alternaria, Ganoderma, Fusarium, Phoma and Xylaria species among others (He et al, 2013;Peng et al 2013: Raekiansyah et al, 2017Zhao et al, 2017;Sillapachaiyaporn & Chuchawankul, 2020) (Table 1).…”
Section: Fungal Bioactive Compounds With Antiviral Effectmentioning
confidence: 99%